Memphis Pharmaceuticals
Last Updated:
- 345.00 EGP
- -11.70
- -3.28%
ممفيس للادوية والصناعات الكيماوية
ممفيس للادوية
Symbol :
MPCI
ISIN :
EGS38351C010
52-Week Range :
130.00
-
490.86
Turnover Ratio :
4.30
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Top News
- A 16-October Memphis Pharmaceutical’s shareholders approve company’s continuity
- B 02-October Memphis Pharmaceutical’s board approves capital raise
- C 14-September Memphis Pharmaceutical approves financing to pay off EGP 300m debt
- D 11-September Memphis Pharmaceutical’s annual profits climb 77%
- E 09-June Memphis Pharmaceutical targets EGP 50m profits in FY22/23
- F 15-March Memphis Pharmaceutical to obtain financing from ADIB
- G 26-January Memphis Pharmaceutical's board approves capital raise to EGP 241m
- H 30-May Memphis Pharmaceutical posts 558% higher profits in 10M
- I 24-March Memphis Pharmaceutical's pretax profit jumps 480% in eight months
- J 20-January Memphis Pharmaceutical’s pretax profit jumps 463% in H1-20/21
- K 26-August Egypt’s FRA approves Memphis Pharmaceutical’s EGP 200m capital raise
- L 23-October Memphis Pharmaceutical's unaudited Q1-19/20 financials turn positive
